CHEST 2022

Peter J. Mazzone, MD, MPH, FCCP, and two other experts reviewed recent changes to lung cancer screening guidelines during a session on October 18 and discussed their impact on historic disparities.

Kamran Mahmood, MD, MPH, will chair a discussion that will explore current approaches to pneumothorax and persistent air leak from a multidisciplinary perspective.

Alice Gallo De Moraes, MD, will chair an interactive review of severe asthma in the ICU that will rely on the audience to choose and discuss the best treatments and strategies.

Parijat Sen, MD, MBBS, FCCP, will help discuss the identification and management of key extrapulmonary manifestations of sarcoidosis during a panel Wednesday afternoon.

Ashley Marie Scott, MD, will help discuss the current evidence for and against the administration of different coagulation factors prior to ICU procedures during a panel discussion Wednesday.

A. Christine Argento, MD, FCCP, will chair a groundbreaking session on current evidence and future pathways for intratumoral therapy in lung cancer treatment.

Bonnie Wang, MD, will chair a session focusing on the variable presentations of acute COVID lung disease, post-COVID organizing pneumonia, and post-COVID fibrosis.

Sunita Kumar, MD, FCCP, will chair a discussion on hypoglossal nerve stimulation therapy; the use of oral appliances; the developing potential for pharmacotherapy; and the utility of weight loss, position therapy, and supplemental oxygen in the treatment of OSA.

This year, the CHEST Foundation awarded more than $600,000 in clinical research and community service grants to 23 individuals.

On Monday, October 17, Christine Won, MD, MSc, and two other sleep medicine experts discussed alternative therapies for patients with obesity hypoventilation for whom positive airway pressure therapy fails.